Defective splicing, disease and therapy: searching for master checkpoints in exon definition

被引:166
|
作者
Buratti, Emanuele [1 ]
Baralle, Marco [1 ]
Baralle, Francisco E. [1 ]
机构
[1] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy
关键词
D O I
10.1093/nar/gkl498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The number of aberrant splicing processes causing human disease is growing exponentially and many recent studies have uncovered some aspects of the unexpectedly complex network of interactions involved in these dysfunctions. As a consequence, our knowledge of the various cis- and trans-acting factors playing a role on both normal and aberrant splicing pathways has been enhanced greatly. However, the resulting information explosion has also uncovered the fact that many splicing systems are not easy to model. In fact we are still unable, with certainty, to predict the outcome of a given genomic variation. Nonetheless, in the midst of all this complexity some hard won lessons have been learned and in this survey we will focus on the importance of the wide sequence context when trying to understand why apparently similar mutations can give rise to different effects. The examples discussed in this summary will highlight the fine 'balance of power' that is often present between all the various regulatory elements that define exon boundaries. In the final part, we shall then discuss possible therapeutic targets and strategies to rescue genetic defects of complex splicing systems.
引用
收藏
页码:3494 / 3510
页数:17
相关论文
共 50 条
  • [21] Alternative splicing in disease and therapy
    Mariano A Garcia-Blanco
    Andrew P Baraniak
    Erika L Lasda
    Nature Biotechnology, 2004, 22 : 535 - 546
  • [22] RNA splicing: disease and therapy
    Douglas, Andrew G. L.
    Wood, Matthew J. A.
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2011, 10 (03) : 151 - 164
  • [23] Alternative splicing in disease and therapy
    Garcia-Blanco, MA
    Baraniak, AP
    Lasda, EL
    NATURE BIOTECHNOLOGY, 2004, 22 (05) : 535 - 546
  • [24] Splicing therapy for neuromuscular disease
    Douglas, Andrew G. L.
    Wood, Matthew J. A.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 56 : 169 - 185
  • [26] Splicing Factor Mutations and Disease Phenotype: Searching for a Needle in a Haystack
    Rouault-Pierre, Kevin
    HEMASPHERE, 2021, 5 (06):
  • [27] RNA SPLICING PERMITS EXPRESSION OF A MAIZE GENE WITH A DEFECTIVE SUPPRESSOR-MUTATOR TRANSPOSABLE ELEMENT INSERTION IN AN EXON
    KIM, HY
    SCHIEFELBEIN, JW
    RABOY, V
    FURTEK, DB
    NELSON, OE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) : 5863 - 5867
  • [28] Targeting RNA splicing for disease therapy
    Havens, Mallory A.
    Duelli, Dominik M.
    Hastings, Michelle L.
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2013, 4 (03) : 247 - 266
  • [29] Defective control of pre-messenger RNA splicing in human disease
    Chabot, Benoit
    Shkreta, Lulzim
    JOURNAL OF CELL BIOLOGY, 2016, 212 (01): : 13 - 27
  • [30] Exon identity crisis: disease-causing mutations that disrupt the splicing code
    Sterne-Weiler, Timothy
    Sanford, Jeremy R.
    GENOME BIOLOGY, 2014, 15 (01):